Your browser doesn't support javascript.
loading
Development of an ectopic huLiver model for Plasmodium liver stage infection.
Samayoa-Reyes, Gabriela; Flaherty, Siobhan M; Wickham, Kristina S; Viera-Morilla, Sara; Strauch, Pamela M; Roth, Alison; Padrón, Laura; Jackson, Conner M; Meireles, Patricia; Calvo, David; Roobsoong, Wanlapa; Kangwanrangsan, Niwat; Sattabongkot, Jetsumon; Reichard, Gregory; Lafuente-Monasterio, Maria José; Rochford, Rosemary.
Afiliação
  • Samayoa-Reyes G; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
  • Flaherty SM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
  • Wickham KS; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Viera-Morilla S; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Strauch PM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
  • Roth A; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Padrón L; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Jackson CM; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
  • Meireles P; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Calvo D; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Roobsoong W; Faculty of Tropical Medicine, Mahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
  • Kangwanrangsan N; Faculty of Science, Pathobiology Department, Mahidol University, Bangkok, Thailand.
  • Sattabongkot J; Faculty of Tropical Medicine, Mahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
  • Reichard G; Department of Drug Discovery, Experimental Therapeutics Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
  • Lafuente-Monasterio MJ; Diseases of the Developing World, Infectious Diseases-Centre for Excellence in Drug Discovery (ID CEDD), GlaxoSmithKline, Tres Cantos, Madrid, Spain.
  • Rochford R; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
PLoS One ; 18(3): e0279144, 2023.
Article em En | MEDLINE | ID: mdl-36928885
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium / Doenças Transmissíveis / Malária Vivax / Malária Falciparum / Hepatopatias / Malária Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasmodium / Doenças Transmissíveis / Malária Vivax / Malária Falciparum / Hepatopatias / Malária Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article